Status:
UNKNOWN
DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome
Lead Sponsor:
Bispebjerg Hospital
Collaborating Sponsors:
H. Lundbeck A/S
Danish Heart Foundation
Conditions:
Depression
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Objective: To evaluate the efficacy of preventive treatment with a selective serotonin reuptake inhibitor (SSRI) (escitalopram) in the first year after acute coronary syndromes (ACS). Methods: 240 pa...
Eligibility Criteria
Inclusion
- ACS
- Randomization within 8 weeks form index hospitalization for ACS
- Age \> 18 years
- Not pregnant
- Signed informed consent
Exclusion
- Current depression
- Use of antidepressants \< 4 weeks
- Previous intolerance to SSRI
- Severe medical conditions
- Severe heart failure
- Alcohol or substance abuse
- Psychosis or dementia
- Current participation in other intervention trials
- Pregnancy and lactation
- Linguistic difficulties
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00140257
Start Date
November 1 2004
Last Update
December 31 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bispebjerg University Hospital
Copenhagen, Denmark, 2400 NV